Overview |
bs-7618R-APC-Cy7 |
NOC2L Polyclonal Antibody, APC-Cy7 Conjugated |
IF(IHC-P), IF(IHC-F), IF(ICC) |
Human, Mouse, Rat, Cow, Sheep, Pig |
Specifications |
APC-Cy7 |
Rabbit |
KLH conjugated synthetic peptide derived from human NOC2L |
251-350/749 |
Polyclonal |
IgG |
1ug/ul |
Purified by Protein A. |
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target |
26155 |
Cytoplasm, Nucleus |
NIR; NOC2 like; Novel INHAT inhibitor of histone acetyltransferase repressor; Nucleolar complex associated 2 homolog S. cerevisiae; Protein NOC2 homolog; NOC2L_HUMAN. |
NOC2L is a transcriptional corepressor with inhibitor of histone acetyltransferase (INHAT) activity. NOC2L or NIR (Novel INHAT Repressor) is ubiquitously expressed throughout embryonic development and adulthood. It is a potent transcriptional corepressor that is not blocked by histone deacetylase inhibitors and is capable of silencing both basal and activator-driven transcription. NOC2L directly binds to nucleosomes and core histones and prevents acetylation by histone acetyltransferases, thus acting as a bona fide INHAT. |
Application Dilution |
IF(IHC-P) |
1:50-200 |
IF(IHC-F) |
1:50-200 |
IF(ICC) |
1:50-200 |